Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
The latest update is out from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ).
Beijing Tong Ren Tang Chinese Medicine Co announced a final cash dividend of HKD 0.35 per share for the year ended December 31, 2024. The dividend will be paid on June 13, 2025, following shareholder approval on May 28, 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders, potentially strengthening its market position and investor confidence.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company operating in the pharmaceutical industry, primarily focusing on the production and distribution of traditional Chinese medicine products. The company is known for its extensive range of herbal medicines and health supplements, catering to a global market with a strong emphasis on traditional Chinese healthcare practices.
YTD Price Performance: -0.31%
Technical Sentiment Signal: Buy
Current Market Cap: $933.3M
Find detailed analytics on 3613 stock on TipRanks’ Stock Analysis page.